Related Experiment Video
Updated: Aug 15, 2025

06:40
Biofunctionalization of Magnetic Nanomaterials
Published on: July 16, 2020
2.7K
Magnetic nanoparticles: multifunctional tool for cancer therapy.
Sumera Khizar1, Eslam Elkalla1, Nadia Zine1
1Univ Lyon, University Cla-ude Bernard Lyon-1, CNRS, ISA-UMR 5280, Lyon, France.
Expert Opinion on Drug Delivery
|January 7, 2023
Summary
Magnetic nanoparticles (MNPs) offer advanced cancer treatment options, including chemo-, immuno-, gene-, and radiotherapy. Their unique properties show promise for improved cancer therapy and clinical translation.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Cancer is a leading cause of global mortality with significant adverse effects from traditional therapies.
- Research is exploring novel therapeutic strategies with improved efficacy and reduced side effects.
- Nanoparticle development for cancer detection and therapy has advanced significantly.
Purpose of the Study:
- To summarize recent advancements in cancer treatment using magnetic nanoparticles (MNPs).
- To discuss the application of MNPs in various cancer therapies, including chemotherapy, immunotherapy, gene therapy, radiotherapy, and hyperthermia.
- To analyze the physicochemical properties, benefits, and limitations of MNPs for clinical application.
Main Methods:
- Review of current research on magnetic nanoparticles for cancer treatment.
- Analysis of MNP applications in diverse therapeutic modalities.
- Evaluation of MNP properties, advantages, and challenges for clinical translation.
Main Results:
- MNPs are being developed as effective cancer therapy modules.
- MNPs exhibit desirable superparamagnetic, chemical, biocompatible, physical, and biodegradable properties.
- These properties make MNPs highly functional tools for targeted cancer treatment.
Conclusions:
- Magnetic nanoparticles represent a promising frontier in cancer therapy.
- Their versatile properties support integration into multiple treatment strategies.
- Further research is needed to overcome limitations for successful clinical translation.

